http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20210095939-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0fcbc9ca53bc68f405f71764197469b5 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-567 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-743 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-567 |
| filingDate | 2019-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0c5cc2230d913de91183234b346ed15 |
| publicationDate | 2021-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20210095939-A |
| titleOfInvention | Treatment of Hypercoagulopathy of Cushing's Syndrome by Administration of Glucocorticoid Receptor Modulators |
| abstract | A novel method of preventing, reducing the risk of, and treating hypercoagulopathy in Cushing's syndrome patients with an elevated risk of developing hypercoagulopathy is disclosed. The method is also useful for preventing, reducing the risk of developing, treating, and treating inflammatory conditions of deep vein embolism (DVT), pulmonary embolism (PE), and venous thromboembolism (VTE). The method comprises: administering to a patient with Cushing's syndrome at risk of developing a hypercoagulopathy a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulator (HKGRM) to treat the hypercoagulopathy. A method of preventing, reducing the risk of developing, and treating DVT, PR, or VTE in a patient with Cushing's syndrome comprises administering to said patient an HKGRM. A method for detecting and subsequently alleviating an inflammatory condition comprises administering to a patient with Cushing's syndrome an effective amount of HKGRM, wherein the effective amount first increases an inflammatory symptom in the patient and then subsequently reduces the inflammatory symptom. effective to do |
| priorityDate | 2018-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 451.